Oxytocic Pharmaceuticals Market Trends, Industry & Size 2031

Segments - Oxytocic Pharmaceuticals Market by Types (Natural Oxytocin and Synthetic Oxytocin Derivative), Applications (Abortion Induced Incomplete, Inevitable Abortion, Post-partum Hemorrhage, Labor Induction, and Labor Arrest), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028.

Author : Raksha Sharma

Fact-checked by : Vineet Pandey

Editor : Vishal Golekar

Report Description

The global oxytocic pharmaceuticals market size is projected to expand at USD 908.53 billion by 2028 at a CAGR of 13.74% during the forecast period. The growth of the market is attributed to child birth and issues related to it.

Oxytocic is a drug used at the end of pregnancy during labor pain and post-delivery which induce to take a selective action on the contraction of smooth musculature of the uterus. Oxytocin is a female reproductive hormone, produced in the hypothalamus and released into bloodstream during childbirth. This hormone induces labor and milk production in a lactating mother.

Drug also monitors the conditions such as post-mature birth, uterine atony, and pre-eclampsia (hyper tension) during pregnancy. World Health Organization states that, every year more than 15 million babies are born prematurely, and this number of preterm births is expected to increase in the coming years. Increasing incidence of preterm births and rising rates of labor induction are the primary factors fueling demand for the global oxytocic pharmaceuticals market.

Market Trends, Drivers, Restraints, and Opportunities

Increasing usage at the end of pregnancy and during labor pain and post-delivery is projected to drive the market.
Increasing child birth rate is anticipated to boost the market.
Availability of alternate drugs and low quality may restrain the market growth.
R&D investment and technological advancement in medical sector is estimated to create lucrative opportunities for the market players.

Scope of Oxytocic Pharmaceuticals Market Report

The report on the global Oxytocic Pharmaceuticals market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes	Details
Report Title	Oxytocic Pharmaceuticals Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
Base Year	2020
Historic Data	2018–2019
Forecast Period	2021–2028
Segmentation	Types (Natural Oxytocin and Synthetic Oxytocin Derivative) and Applications (Abortion Induced Incomplete, Inevitable Abortion, Post-partum Hemorrhage, Labor Induction, and Labor Arrest)
Regional Scope	Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
Report Coverage	Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
Key Players Covered in the Report	Fresenius Kaci, Biofutura, Baxter, Pfizer, and Ferring, Novartis, and Teva.

Oxytocic Pharmaceuticals Market Segment Insights

The synthetic segment is estimated to hold major market share

Based on types, the global oxytocic pharmaceuticals market is fragmented as natural oxytocin and synthetic oxytocin derivative. The synthetic segment is projected to expand at a rapid pace during the forecast period. Medical professionals from around the world recommend synthetic-based oxytocic pharmaceuticals over natural since oxytocic pharmaceuticals originating from synthetic sources can boost the momentum of decelerated labor by IV administration.

The labor induction segment is estimated to expand at a high CAGR

On the basis of applications, the global oxytocic pharmaceuticals market is segregated into abortion induced incomplete, inevitable abortion, post-partum hemorrhage, labor induction, and labor arrest. The labor induction segment is anticipated to hold major market share during the forecast period. Oxytocic drugs are used after the birth and if the patient is unable to deliver the child. The drug helps in reducing the pain and stops the bleeding which takes place post child birth. Other use of the drug is when a patient is experiencing hyper tension during the delivery time.

Oxytocic Pharmaceuticals Market Application

The market in North America is projected to hold a major market share

In terms of regions, the global oxytocic pharmaceuticals market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market in North America is subjected to hold major share during the forecast period. In North America, oxytocic pharmaceuticals are majorly used for postpartum hemorrhage, which is one of the most-prominent indication among labouring women in the US and Canada. The market in Europe is expected to grow at a rapid pace, due to the rise in oxytocin administration in response to the increasing number of elective caesareans.

The market in Asia Pacific is estimate to grow parallelly due to the high population and high birth rate. India and China are the leading in these factors. Prevalence of post-partum hemorrhage is 8.5% in Asian countries. China's single child policy to two children policy is estimated to increase the incidence of post - partum hemorrhage.

Segments

The global oxytocic pharmaceuticals market is segmented on the basis of

Types

Natural Oxytocin
Synthetic Oxytocin Derivative

Applications

Abortion Induced Incomplete
Inevitable Abortion
Post-partum Hemorrhage
Labour Induction
Labour Arrest

Regions

Asia Pacific
North America
Latin America
Europe

Key Players

Fresenius Kaci
Biofutura
Baxter
Pfizer
Ferring
Novartis
Teva

Competitive Landscape

Major players in the global oxytocic pharmaceuticals market include Fresenius Kaci, Biofutura, Baxter, Pfizer, Ferring, Novartis, and Teva. These companies are investing in the research and development of the oxytocic. Business strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches are used by major players to increase their market shares. The United Nations is focused on achieving the global maternal mortality ration target of less than 70 per 100000 live births under its project (Sustainable Development Goal 2030).

Oxytocic Pharmaceuticals Market Share

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Oxytocic Pharmaceuticals Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Oxytocic Pharmaceuticals Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Oxytocic Pharmaceuticals Market - Supply Chain
  4.5. Global Oxytocic Pharmaceuticals Market Forecast
     4.5.1. Oxytocic Pharmaceuticals Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Oxytocic Pharmaceuticals Market Size (000â€™ Units) and Y-o-Y Growth
     4.5.3. Oxytocic Pharmaceuticals Market Absolute $ Opportunity
5. Global Oxytocic Pharmaceuticals Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Oxytocic Pharmaceuticals Market Size and Volume Forecast by Types
     5.3.1. Natural Oxytocin
     5.3.2. Synthetic Oxytocin Derivative
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Oxytocic Pharmaceuticals Market Analysis and Forecast by Applications
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Applications
     6.2.2. Y-o-Y Growth Projections by Applications
  6.3. Oxytocic Pharmaceuticals Market Size and Volume Forecast by Applications
     6.3.1. Abortion Induced Incomplete
     6.3.2. Inevitable Abortion
     6.3.3. Post-partum Hemorrhage
     6.3.4. Labour Induction
     6.3.5. Labour Arrest
  6.4. Absolute $ Opportunity Assessment by Applications
  6.5. Market Attractiveness/Growth Potential Analysis by Applications
7. Global Oxytocic Pharmaceuticals Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. Oxytocic Pharmaceuticals Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global Oxytocic Pharmaceuticals Demand Share Forecast, 2019-2026
8. North America Oxytocic Pharmaceuticals Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America Oxytocic Pharmaceuticals Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America Oxytocic Pharmaceuticals Market Size and Volume Forecast by Types
     8.4.1. Natural Oxytocin
     8.4.2. Synthetic Oxytocin Derivative
  8.5. Basis Point Share (BPS) Analysis by Types
  8.6. Y-o-Y Growth Projections by Types
  8.7. North America Oxytocic Pharmaceuticals Market Size and Volume Forecast by Applications
     8.7.1. Abortion Induced Incomplete
     8.7.2. Inevitable Abortion
     8.7.3. Post-partum Hemorrhage
     8.7.4. Labour Induction
     8.7.5. Labour Arrest
  8.8. Basis Point Share (BPS) Analysis by Applications
  8.9. Y-o-Y Growth Projections by Applications
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America Oxytocic Pharmaceuticals Demand Share Forecast, 2019-2026
9. Latin America Oxytocic Pharmaceuticals Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America Oxytocic Pharmaceuticals Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America Oxytocic Pharmaceuticals Market Size and Volume Forecast by Types
     9.4.1. Natural Oxytocin
     9.4.2. Synthetic Oxytocin Derivative
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. Latin America Oxytocic Pharmaceuticals Market Size and Volume Forecast by Applications
     9.7.1. Abortion Induced Incomplete
     9.7.2. Inevitable Abortion
     9.7.3. Post-partum Hemorrhage
     9.7.4. Labour Induction
     9.7.5. Labour Arrest
  9.8. Basis Point Share (BPS) Analysis by Applications
  9.9. Y-o-Y Growth Projections by Applications
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America Oxytocic Pharmaceuticals Demand Share Forecast, 2019-2026
10. Europe Oxytocic Pharmaceuticals Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe Oxytocic Pharmaceuticals Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe Oxytocic Pharmaceuticals Market Size and Volume Forecast by Types
     10.4.1. Natural Oxytocin
     10.4.2. Synthetic Oxytocin Derivative
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Europe Oxytocic Pharmaceuticals Market Size and Volume Forecast by Applications
     10.7.1. Abortion Induced Incomplete
     10.7.2. Inevitable Abortion
     10.7.3. Post-partum Hemorrhage
     10.7.4. Labour Induction
     10.7.5. Labour Arrest
  10.8. Basis Point Share (BPS) Analysis by Applications
  10.9. Y-o-Y Growth Projections by Applications
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe Oxytocic Pharmaceuticals Demand Share Forecast, 2019-2026
11. Asia Pacific Oxytocic Pharmaceuticals Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific Oxytocic Pharmaceuticals Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific Oxytocic Pharmaceuticals Market Size and Volume Forecast by Types
     11.4.1. Natural Oxytocin
     11.4.2. Synthetic Oxytocin Derivative
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Asia Pacific Oxytocic Pharmaceuticals Market Size and Volume Forecast by Applications
     11.7.1. Abortion Induced Incomplete
     11.7.2. Inevitable Abortion
     11.7.3. Post-partum Hemorrhage
     11.7.4. Labour Induction
     11.7.5. Labour Arrest
  11.8. Basis Point Share (BPS) Analysis by Applications
  11.9. Y-o-Y Growth Projections by Applications
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific Oxytocic Pharmaceuticals Demand Share Forecast, 2019-2026
12. Middle East & Africa Oxytocic Pharmaceuticals Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa Oxytocic Pharmaceuticals Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa Oxytocic Pharmaceuticals Market Size and Volume Forecast by Types
     12.4.1. Natural Oxytocin
     12.4.2. Synthetic Oxytocin Derivative
  12.5. Basis Point Share (BPS) Analysis by Types
  12.6. Y-o-Y Growth Projections by Types
  12.7. Middle East & Africa Oxytocic Pharmaceuticals Market Size and Volume Forecast by Applications
     12.7.1. Abortion Induced Incomplete
     12.7.2. Inevitable Abortion
     12.7.3. Post-partum Hemorrhage
     12.7.4. Labour Induction
     12.7.5. Labour Arrest
  12.8. Basis Point Share (BPS) Analysis by Applications
  12.9. Y-o-Y Growth Projections by Applications
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa Oxytocic Pharmaceuticals Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global Oxytocic Pharmaceuticals Market: Market Share Analysis
  13.2. Oxytocic Pharmaceuticals Distributors and Customers
  13.3. Oxytocic Pharmaceuticals Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. Fresenius Kaci
     13.4.2. Biofutura
     13.4.3. Baxter
     13.4.4. Pfizer
     13.4.5. Ferring
     13.4.6. Novartis
     13.4.7. Teva